Skip to main content
ADUSAddus HomeCare CorporationHold5.7·$117.09-1.21%

Addus HomeCare (ADUS) Q2 2026 earnings — TrendMatrix coverage

BEAT+1.9% vs estimateEPS $1.73 vs $1.70 estCurrent verdict Hold 5.7/10

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$1.73
Estimate
$1.70
Surprise
+1.9%
Score today
5.7/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Report record · Q2 2026

How the report landed

Addus HomeCare (ADUS) beat the $1.70 estimate with diluted EPS of $1.73 — a modest 1.9% upside surprise.

Current read · as of 2026-09-14

Where TrendMatrix's rating stands now

TrendMatrix currently rates ADUS Hold at 5.7/10; no pre/post engine snapshot brackets this report.

4 of the last 4 quarters beat the estimate; this quarter's +1.9% surprise compares with a +2.8% four-quarter average. Next scheduled report: 2026-11-02.

What supports the rating

  • Sector modifier (Healthcare): +0.5
  • Strong earnings beat streak (4/4)

What argues against it

  • Analyst target reached - limited upside remaining
  • V7 low-quality RISK_OFF penalty: -0.5 (Q=5.2)
  • Negative momentum

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$117.09
Price target
$117.18
Stop
$111.15
Upside to target
+0.1%
Reward-to-risk
0.0:1

The stock trades at 20.5× trailing but 15.6× forward earnings — consensus estimates already build in a substantial earnings recovery.

Model outputs from TrendMatrix’s engine as of 2026-09-14 — shown for context, not personalized investment advice.

Healthcare context

ADUS at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Care Facilities
Market cap
$2.19B
P/E (fwd)
15.6
P/E (ttm)
20.5
52-week range
$87.95$124.44
Off 52-week high
5.9%
RSI (14)
37
Volume vs avg
0.71×
Score today
5.7/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks ADUS Earnings Q2 2026 earnings